One of the areas in which Vétoquinol excels is antibiotic therapy, a category of treatment in which the laboratory is constantly making innovations. Vétoquinol’s expertise in this area has resulted in the development of marbofloxacin, a third generation fluoroquinolone which is used exclusively in veterinary medicine. Marbofloxacin, available under the brand name Marbocyl®, has exceptional pharmacodynamic and pharmacokinetic properties, making it remarkably effective.
Marbofloxacin is a synthetic, bactericidal anti-infective agent, belonging to the fluoroquinolone family. It acts by inhibiting DNA- gyrase. It has a broad spectrum, active against Gram positive bacteria (particularly Staphylococcus), Gram negative bacteria (Escherichia coli, Pasteurella spp.) and mycoplasma (Mycoplasma bovis and M. hyopneumoniae). |
